These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8300049)

  • 21. Somatostatin inhibition of growth hormone secretion by somatotropes from male, female, and androgen receptor-deficient rats: evidence for differing sensitivities.
    Kerrigan JR; Martha PM; Krieg RJ; Rogol AD; Evans WS
    Endocrinology; 1989 Dec; 125(6):3078-83. PubMed ID: 2573509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of growth hormone (GH) gene expression and secretion during pregnancy and lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing hormone.
    Escalada J; Sánchez-Franco F; Velasco B; Cacicedo L
    Endocrinology; 1997 Aug; 138(8):3435-43. PubMed ID: 9231798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study.
    Veldhuis JD; Roemmich JN; Rogol AD
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2385-94. PubMed ID: 10902783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrient Sensing Overrides Somatostatin and Growth Hormone-Releasing Hormone to Control Pulsatile Growth Hormone Release.
    Steyn FJ
    J Neuroendocrinol; 2015 Jul; 27(7):577-87. PubMed ID: 25808924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone.
    Tannenbaum GS; Gurd W; Lapointe M
    Endocrinology; 1998 Sep; 139(9):3871-5. PubMed ID: 9724042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day.
    Van Cauter E; Kerkhofs M; Caufriez A; Van Onderbergen A; Thorner MO; Copinschi G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1441-50. PubMed ID: 1592892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
    Koutkia P; Canavan B; Breu J; Johnson ML; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E506-12. PubMed ID: 15138154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the hypothalamic control of growth hormone secretion.
    MacGregor DJ; Leng G
    J Neuroendocrinol; 2005 Dec; 17(12):788-803. PubMed ID: 16280026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans.
    Devesa J; Lois N; Arce V; Diaz MJ; Lima L; Tresguerres JA
    J Steroid Biochem Mol Biol; 1991; 40(1-3):165-73. PubMed ID: 1958517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion.
    Tannenbaum GS; Epelbaum J; Bowers CY
    Endocrinology; 2003 Mar; 144(3):967-74. PubMed ID: 12586774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals.
    Müller EE; Cella SG; De Gennaro Colonna V; Parenti M; Cocchi D; Locatelli V
    J Reprod Fertil Suppl; 1993; 46():99-114. PubMed ID: 8100277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression of hypothalamic growth hormone (GH)-releasing hormone and somatostatin does not correlate with pulsatile secretion of GH in the adult mouse.
    Murao S; Sato M; Tamaki M; Niimi M; Ishida T; Takahara J
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):269-77. PubMed ID: 8680796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
    Ionescu M; Frohman LA
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4792-7. PubMed ID: 17018654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.